Efficiency and safety of single anastomosis sleeve ileal (SASI) bypass in the treatment of obesity and associated comorbidities: a systematic review and meta-analysis - Scorecard - MDSpire

Efficiency and safety of single anastomosis sleeve ileal (SASI) bypass in the treatment of obesity and associated comorbidities: a systematic review and meta-analysis

  • By

  • Carolina Rodrigues Oliveira

  • Hugo Santos-Sousa

  • Maria Pinho Costa

  • Filipe Amorim-Cruz

  • Raquel Bouça-Machado

  • Jorge Nogueiro

  • Fernando Resende

  • André Costa-Pinho

  • John Preto

  • Eduardo Lima-da-Costa

  • Silvestre Carneiro

  • Bernardo Sousa-Pinto

  • July 18, 2024

  • 0 min

Share

Clinical Scorecard: Efficacy and Safety of Single Anastomosis Sleeve Ileal Bypass for Obesity and Related Comorbidities: A Systematic Review and Meta-Analysis

At a Glance

CategoryDetail
ConditionObesity and related comorbidities (T2DM, hypertension, dyslipidemia, GERD, OSA)
Key MechanismsSingle Anastomosis Sleeve Ileal (SASI) bypass combines sleeve gastrectomy with loop gastroileostomy creating a simpler loop anastomosis to induce weight loss and improve metabolic comorbidities
Target PopulationAdult patients with obesity undergoing bariatric surgery
Care SettingSurgical bariatric care settings including hospitals performing laparoscopic bariatric procedures

Key Highlights

  • SASI bypass is a newer bariatric technique first described in 2014, combining sleeve gastrectomy with a loop gastroileostomy 200-350 cm proximal to the ileocecal valve.
  • Systematic review included 18 studies (retrospective, prospective, and one RCT) assessing SASI bypass efficacy and safety compared to other bariatric surgeries like SG and OAGB.
  • Meta-analysis evaluated outcomes including percentage excess weight loss (%EWL), remission/improvement of T2DM, hypertension, dyslipidemia, OSA, and surgical complications.

Guideline-Based Recommendations

Diagnosis

  • Assess adult patients with obesity and related comorbidities as candidates for bariatric surgery including SASI bypass.

Management

  • Consider SASI bypass as a surgical option for obesity treatment, especially when simpler and potentially safer alternatives to Roux-en-Y gastric bypass are desired.
  • Customize common limb length between 200 and 350 cm based on patient characteristics and surgical preference.

Monitoring & Follow-up

  • Monitor weight loss outcomes using %EWL and BMI changes postoperatively.
  • Evaluate improvement or remission of obesity-related comorbidities such as T2DM, hypertension, dyslipidemia, GERD, and OSA.
  • Track and manage postoperative complications systematically.

Risks

  • Recognize potential surgical complications inherent to bariatric procedures; SASI bypass may have a safety profile comparable or improved relative to other techniques.
  • Consider heterogeneity in outcomes due to variation in surgical technique and limb length.

Patient & Prescribing Data

Adults with obesity undergoing bariatric surgery

SASI bypass shows promising efficacy in weight loss and comorbidity improvement with a simpler surgical approach; however, data are derived from observational studies and limited RCT evidence.

Clinical Best Practices

  • Use standardized protocols for patient selection and preoperative evaluation for SASI bypass.
  • Apply consistent surgical technique with attention to common limb length to optimize outcomes.
  • Implement rigorous postoperative follow-up to assess weight loss, comorbidity resolution, and detect complications early.
  • Utilize multidisciplinary teams including surgeons, endocrinologists, and dietitians for comprehensive care.

References

Original Source(s)

Related Content